In 2023, Mindray partnered with HyTest to innovate from the ground up, developing the highly sensitive cardiac troponin I (hs-cTnI), which sets a new standard for reliability in this field. Since the launch of Mindray's hs-cTnI, it has achieved remarkable success and has been widely recognized by leading global medical institutions such as the IFCC, as well as by top cardiac experts worldwide.
The IFCC C-CB, or Committee on Clinical Applications of Cardiac Bio-Markers, operates within the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). This committee is dedicated to creating educational documents, materials, and scientific presentations that advance the clinical and analytical use of cardiac biomarkers. Mindray is proud to be a corporate member of the IFCC C-CB, contributing to progress in this vital field.
The evaluation of cardiac assays is of paramount importance for clinical applications. To support this, the IFCC C-CB collaborates with leading companies to produce annual updates of online tables, offering invaluable resources for new users and authors seeking the latest performance characteristics of available assays. In the most recent update (v062024), Mindray's hs-cTnI demonstrated an impressive 93% detection rate in healthy populations, firmly establishing its reputation as one of the premier hs-cTnI assays available today.
Recently, Professor Fred S. Apple, former chair of the IFCC C-CB, published an article in the journal "Clinical Chemistry and Laboratory Medicine" (IF 6.8), detailing the performance evaluation of Mindray's hs-cTnI assay.
The latest update highlights Mindray's dedication to delivering accurate and reliable cardiac biomarker assessments, which are crucial for clinical applications.
References:
[1] High-Sensitivity-Cardiac-Troponin-I-and-T-Assay-Analytical-Characteristics-Designated-By-Manufacturer-v062024.pdf (pub-180a8d00f517477ba49634e6b2b147e3.r2.dev)
[2] Fabre-Estremera, Blanca, Schulz, Karen, Ladd, Alanna, Sexter, Anne and Apple, Fred S.. "Analytical validation of the Mindray CL1200i analyzer high sensitivity cardiac troponin I assay: MERITnI study" Clinical Chemistry and Laboratory Medicine (CCLM), 2024. https://doi.org/10.1515/cclm-2024-0352
